Cerenome (CNSY) EBIT Margin Growth (3y) (2014 - 2026)
Powered by 
Analysis
Cerenome (CNSY) EBIT Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 7,045.00 |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -1,934.00 |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 7,261.00 |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 9,003.00 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | -2,649.00 |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 30,461.00 |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | -212,523.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -212,523.00 |
| Mar 31, 2026 | 24,069.00 |
| Dec 31, 2025 | 327,002.00 |
| Sep 30, 2025 | 665,725.00 |
| Mar 31, 2019 | 7,426.00 |
| Dec 31, 2018 | -77.00 |
| Sep 30, 2018 | -52,026.00 |
| Jun 30, 2018 | -63,856.00 |
| Mar 31, 2018 | 173,248.00 |
| Dec 31, 2017 | -37,349.00 |
| Sep 30, 2017 | 59,319.00 |
| Jun 30, 2017 | 56,683.00 |
| Mar 31, 2017 | -28,027.00 |
| Dec 31, 2016 | 9,203.00 |
| Sep 30, 2016 | -13,265.00 |
| Jun 30, 2016 | -10,084.00 |
| Mar 31, 2016 | 10,161.00 |
| Dec 31, 2015 | -6,395.00 |
| Sep 30, 2015 | 104,701.00 |
| Jun 30, 2015 | 71,633.00 |